Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shan Dong Kexing Bioproducts Co's enterprise value is ¥5,047 Mil.
Shan Dong Kexing Bioproducts Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ¥271 Mil. Therefore, Shan Dong Kexing Bioproducts Co's EV-to-EBITDA for today is 18.63.
The historical rank and industry rank for Shan Dong Kexing Bioproducts Co's EV-to-EBITDA or its related term are showing as below:
SHSE:688136'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -116.55 Med: 28.63 Max: 225.59
Current: 18.63
During the past 9 years, the highest EV-to-EBITDA of Shan Dong Kexing Bioproducts Co was 225.59. The lowest was -116.55. And the median was 28.63.
SHSE:688136's EV-to-EBITDA is ranked worse than 55.75% of 400
companies
in the Biotechnology industry
Industry Median: 14
vs SHSE:688136: 18.63
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Shan Dong Kexing Bioproducts Co (SHSE:688136) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shan Dong Kexing Bioproducts Co's PE Ratio (TTM) for today is calculated as:
Shan Dong Kexing Bioproducts Co's share price for today is ¥20.70.
Shan Dong Kexing Bioproducts Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.060.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shan Dong Kexing Bioproducts Co EV-to-EBITDA Chart
SHSE:688136 vs VRTX, REGN, MRNA: EV-to-EBITDA Comparison
For the Biotechnology subindustry, Shan Dong Kexing Bioproducts Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shan Dong Kexing Bioproducts Co EV-to-EBITDA vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shan Dong Kexing Bioproducts Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Shan Dong Kexing Bioproducts Co's EV-to-EBITDA falls into.
Shan Dong Kexing Bioproducts Co's current Enterprise Value is ¥5,047 Mil.
Shan Dong Kexing Bioproducts Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥271 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shan Dong Kexing Bioproducts Co (SHSE:688136) has a EV-to-EBITDA of 18.63 as of Sep. 03, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Shan Dong Kexing Bioproducts Co. This is 35% below median its historical median of 28.63. According to the industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #223 out of 400 companies in the Biotechnology industry, placing it in the top 55.7%.
Is Shan Dong Kexing Bioproducts Co's EV-to-EBITDA too high?
Shan Dong Kexing Bioproducts Co's current EV-to-EBITDA of 18.63 is 35% below median its 10-year median of 28.63. The Biotechnology industry median EV-to-EBITDA is 14.00. Shan Dong Kexing Bioproducts Co's value of 18.63 is 33.1% above this industry median. Based on the distribution chart, Shan Dong Kexing Bioproducts Co ranks #223 out of 400 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Shan Dong Kexing Bioproducts Co has a GF Score™ of 46/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shan Dong Kexing Bioproducts Co's EV-to-EBITDA compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #223 out of 400 companies for EV-to-EBITDA. This places Shan Dong Kexing Bioproducts Co in the lower half of its industry. The industry median EV-to-EBITDA is 14.00. Shan Dong Kexing Bioproducts Co's value of 18.63 is 33.1% above this benchmark. While the company's 10-year median is 28.63 vs. the industry median of 14.00, Shan Dong Kexing Bioproducts Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Biotechnology company?
The median EV-to-EBITDA among Biotechnology companies is 14.00, based on 400 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shan Dong Kexing Bioproducts Co's current EV-to-EBITDA of 18.63 is 33.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Shan Dong Kexing Bioproducts Co. For the Biotechnology industry, the median EV-to-EBITDA is 14.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shan Dong Kexing Bioproducts Co's current EV-to-EBITDA is 18.63, which is 35% below median its own 10-year median of 28.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shan Dong Kexing Bioproducts Co stock overvalued right now?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co (SHSE:688136) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.19, compared to a current price of ¥20.70 — trading 10.7% below its estimated fair value. The current EV-to-EBITDA is 18.63, which is 35% below median its 10-year median of 28.63 and 33.1% above the Biotechnology industry median of 14.00. Shan Dong Kexing Bioproducts Co's overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Shan Dong Kexing Bioproducts Co (SHSE:688136), the current EV-to-EBITDA is 18.63 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shan Dong Kexing Bioproducts Co (SHSE:688136) Overvalued in 2026?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co stock appears to be undervalued.
The current stock price of ¥20.70 is trading 10.7% below its estimated GF Value™ of ¥23.19.
GuruFocus considers Shan Dong Kexing Bioproducts Co to be Modestly Undervalued.
Key valuation signals for SHSE:688136:
EV-to-EBITDA: 18.63 (35% below median its 10-year median of 28.63)
GF Value™: ¥23.19 vs. price of ¥20.70 (10.7% below fair value)
Industry Position: 33.1% above the Biotechnology median (#223 of 400)
No single metric tells the full story. See the SHSE:688136 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
46GF Score
Get the complete analysis for SHSE:688136
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688136 has been successfully added to your 
